Other Combinations of Triple Agonism in Development GLP1/GIP/GCG is the only combination of hormone receptor agonism under investigation as a unimolecular triple agonist in phase 2 or 3 trials for obesity
That distinction matters for understanding why systemic IGF-1 LR3 administration and local MGF activity are not equivalent in their biological targets, even though both ultimately activate many of the same downstream signalling nodes
355 , i5340 (2016)
This process, called delayed gastric emptying, helps people feel full longer and eat less
The LEADER trial enrolled patients with T2DM and high cardiovascular risk, defined as established CVD (81%) or age 60 years with at least one risk factor, and showed that liraglutide significantly reduced the incidence of 3-point major adverse cardiovascular events (MACE) (i.e., CV death, non-fatal myocardial infarction, non-fatal stroke) by 13% compared to placebo (HR 0.87
She was a widower, lost her husband 3 years before the ESKD diagnosis, and had three supportive daughters who were always there during her illness
